Abstract
The interaction between brain and heart involves many actors, among which the sympathetic nervous system plays a major role. Since the first description of adrenoceptors by Raymond Ahlquist in 1948 and the use of beta-blockers by Sir James W. Black in patients with angina pectoris 10 years later, molecular cardiology has been investigating the intimate mechanisms enabling cardiac muscle to adapt (or maladapt) to emotional stress or physical demand. This continuous effort, exploiting state-of-the-art technologies to date, led to an impressive progress in our understanding of the machinery nearby the beta-adrenergic receptor and underneath, much more complex than imagined by pioneering studies of neural-brain axis. This review examines the features of these receptors – subtypes, localization, pathways, and effectors – mediating electrophysiological response of cardiomyocytes, with particular emphasis to control of excitation contraction coupling mechanisms and implications for arrhythmogenesis and cardiomyopathies.
Similar content being viewed by others
References
Musheshe N, Schmidt M, Zaccolo M. cAMP: from long-range second messenger to nanodomain signalling. Trends Pharmacol Sci. 2018;39(2):209–22.
Laudette M, Zuo H, Lezoualc’h F, Schmidt M. Epac function and cAMP scaffolds in the heart and lung. J Cardiovasc Dev Dis. 2018;5(1):9.
**ao RP, Ji X, Lakatta EG. Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol. 1995;47(2):322–9.
Sartiani L, Mannaioni G, Masi A, Romanelli MN, Cerbai E. The hyperpolarization-activated cyclic nucleotide–gated channels: from biophysics to pharmacology of a unique family of ion channels. Pharmacol Rev. 2017;69(4):354–95.
Nikolaev VO, Moshkov A, Lyon AR, Miragoli M, Novak P, Paur H, et al. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science. 2010;327(5973):1653–7.
Sanchez-Alonso JL, Bhargava A, O’Hara T, Glukhov AV, Schobesberger S, Bhogal N, et al. Microdomain-specific modulation of L-type calcium channels leads to triggered ventricular arrhythmia in heart failure. Circ Res. 2016;119(8):944–55.
Wright PT, Bhogal NK, Diakonov I, Pannell LMK, Perera RK, Bork NI, et al. Cardiomyocyte membrane structure and cAMP Compartmentation produce anatomical variation in beta2AR-cAMP responsiveness in murine hearts. Cell Rep. 2018;23(2):459–69.
Gauthier C, Leblais V, Kobzik L, Trochu JN, Khandoudi N, Bril A, et al. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest. 1998;102(7):1377–84.
Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H. Functional beta3-adrenoceptor in the human heart. J Clin Invest. 1996;98(2):556–62.
Spinelli V, Sartiani L, Mugelli A, Romanelli MN, Cerbai E. Hyperpolarization-activated cyclic-nucleotide-gated channels: pathophysiological, developmental, and pharmacological insights into their function in cellular excitability. Can J Physiol Pharmacol. 2018;96(10):977–84.
Prando V, Da Broi F, Franzoso M, Plazzo AP, Pianca N, Francolini M, et al. Dynamics of neuroeffector coupling at cardiac sympathetic synapses. J Physiol. 2018;596(11):2055–75.
Zamponi GW, Striessnig J, Koschak A, Dolphin AC. The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacol Rev. 2015;67(4):821–70.
Jost N, Virág L, Bitay M, Takács J, Lengyel C, Biliczki P, et al. Restricting excessive cardiac action potential and QT prolongation. Circulation. 2005;112:1392–9.
Campbell AS, Johnstone SR, Baillie GS, Smith G. Beta-adrenergic modulation of myocardial conduction velocity: connexins vs. sodium current. J Mol Cell Cardiol. 2014;77:147–54.
Coppini R, Ferrantini C, Yao L, Fan P, Del Lungo M, Stillitano F, et al. Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy. Circulation. 2013;127(5):575–84.
Coppini R, Mazzoni L, Ferrantini C, Gentile F, Pioner JM, Laurino A, et al. Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy. Circ Heart Fail. 2017;0(3). pii: e003565.
Zankov DP, Yoshida H, Tsuji K, Toyoda F, Ding WG, Matsuura H, et al. Adrenergic regulation of the rapid component of delayed rectifier K+ current: implications for arrhythmogenesis in LQT2 patients. Heart Rhythm. 2009;6(7):1038–46.
Bosch RF, Schneck AC, Kiehn J, Zhang W, Hambrock A, Eigenberger BW, et al. beta3-adrenergic regulation of an ion channel in the heart-inhibition of the slow delayed rectifier potassium current I(Ks) in guinea pig ventricular myocytes. Cardiovasc Res. 2002;56(3):393–403.
Ferrantini C, Pioner JM, Mazzoni L, Gentile F, Tosi B, Rossi A, et al. Late sodium current inhibitors to treat exercise-induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium. Br J Pharmacol. 2018;175(13):2635–52.
Kang C, Badiceanu A, Brennan JA, Gloschat C, Qiao Y, Trayanova NA, et al. Beta-adrenergic stimulation augments transmural dispersion of repolarization via modulation of delayed rectifier currents IKs and IKr in the human ventricle. Sci Rep. 2017;7(1):15922.
Cerbai E, Barbieri M, Mugelli A. Occurrence and properties of the hyperpolarization-activated current if in ventricular myocytes from normotensive and hypertensive rats during aging. Circulation. 1996;94(7):1674–81.
Stillitano F, Lonardo G, Zicha S, Varro A, Cerbai E, Mugelli A, et al. Molecular basis of funny current (I(f)) in normal and failing human heart. J Mol Cell Cardiol. 2008;45(2):289–99.
Cerbai E, Pino R, Sartiani L, Mugelli A. Influence of postnatal-development on I(f) occurrence and properties in neonatal rat ventricular myocytes. Cardiovasc Res. 1999;42(2):416–23.
Fernandez-Tenorio M, Niggli E. Stabilization of Ca(2+) signaling in cardiac muscle by stimulation of SERCA. J Mol Cell Cardiol. 2018;119:87–95.
Lezcano N, Mariangelo JIE, Vittone L, Wehrens XHT, Said M, Mundina-Weilenmann C. Early effects of Epac depend on the fine-tuning of the sarcoplasmic reticulum Ca(2+) handling in cardiomyocytes. J Mol Cell Cardiol. 2018;114:1–9.
Dote K, Sato H, Tateishi H, Uchida T, Ishihara M. Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol. 1991;21(2):203–14.
Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352(6):539–48.
Ellison GM, Torella D, Karakikes I, Purushothaman S, Curcio A, Gasparri C, et al. Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells. J Biol Chem. 2007;282(15):11397–409.
Paur H, Wright PT, Sikkel MB, Tranter MH, Mansfield C, O’Gara P, et al. High levels of circulating epinephrine trigger apical cardiodepression in a beta2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation. 2012;126(6):697–706.
Crocini C, Coppini R, Ferrantini C, Yan P, Loew LM, Poggesi C, et al. T-tubular electrical defects contribute to blunted beta-adrenergic response in heart failure. Int J Mol Sci. 2016;17(9). pii: E1471.
Crocini C, Coppini R, Ferrantini C, Yan P, Loew LM, Tesi C, et al. Defects in T-tubular electrical activity underlie local alterations of calcium release in heart failure. Proc Natl Acad Sci U S A. 2014;111(42):15196–201.
Ferrantini C, Crocini C, Coppini R, Vanzi F, Tesi C, Cerbai E, et al. The transverse-axial tubular system of cardiomyocytes. Cell Mol Life Sci. 2013;70(24):4695–710.
Lefkimmiatis K, Zaccolo M. cAMP signaling in subcellular compartments. Pharmacol Ther. 2014;143(3):295–304.
Leroy J, Abi-Gerges A, Nikolaev VO, Richter W, Lechene P, Mazet JL, et al. Spatiotemporal dynamics of beta-adrenergic cAMP signals and L-type Ca2+ channel regulation in adult rat ventricular myocytes: role of phosphodiesterases. Circ Res. 2008;102(9):1091–100.
Zhang Y, Knight W, Chen S, Mohan A, Yan C. Multiprotein complex with TRPC (transient receptor potential-canonical) channel, PDE1C (phosphodiesterase 1C), and A2R (adenosine A2 receptor) plays a critical role in regulating cardiomyocyte cAMP and survival. Circulation. 2018;138(18):1988–2002.
Hashimoto T, Kim GE, Tunin RS, Adesiyun T, Hsu S, Nakagawa R, et al. Acute enhancement of cardiac function by phosphodiesterase type 1 inhibition. Circulation. 2018;138(18):1974–87.
Carling D. The AMP-activated protein kinase cascade – a unifying system for energy control. Trends Biochem Sci. 2004;29(1):18–24.
Harada M, Nattel SN, Nattel S. AMP-activated protein kinase: potential role in cardiac electrophysiology and arrhythmias. Circ Arrhythm Electrophysiol. 2012;5(4):860–7.
Baruscotti M, Bianco E, Bucchi A, DiFrancesco D. Current understanding of the pathophysiological mechanisms responsible for inappropriate sinus tachycardia: role of the if “funny” current. J Interv Card Electrophysiol. 2016;46(1):19–28.
D’Souza A, Bucchi A, Johnsen AB, Logantha SJ, Monfredi O, Yanni J, et al. Exercise training reduces resting heart rate via downregulation of the funny channel HCN4. Nat Commun. 2014;5:3775.
Lonardo G, Cerbai E, Casini S, Giunti G, Bonacchi M, Battaglia F, et al. Pharmacological modulation of the hyperpolarization- activated current (I-f) in human atrial myocytes: focus on G protein-coupled receptors. J Mol Cell Cardiol. 2005;38(3):453–60.
Pino R, Cerbai E, Calamai G, Alajmo F, Borgioli A, Braconi L, et al. Effect of 5-HT4 receptor stimulation on the pacemaker current I(f) in human isolated atrial myocytes. Cardiovasc Res. 1998;40(3):516–22.
Lonardo G, Cerbai E, Casini S, Giunti G, Bonacchi M, Battaglia F, et al. Atrial natriuretic peptide modulates the hyperpolarization-activated current (I-f) in human atrial myocytes. Cardiovasc Res. 2004;63(3):528–36.
Suffredini S, Stillitano F, Comini L, Bouly M, Brogioni S, Ceconi C, et al. Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression. Br J Pharmacol. 2012;165(5):1457–66.
Kuwabara Y, Kuwahara K, Takano M, Kinoshita H, Arai Y, Yasuno S, et al. Increased expression of HCN channels in the ventricular myocardium contributes to enhanced arrhythmicity in mouse failing hearts. J Am Heart Assoc. 2013;2(3):e000150.
Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001;103(2):196–200.
Ferrantini C, Coppini R, Scellini B, Ferrara C, Pioner JM, Mazzoni L, et al. R4496C RyR2 mutation impairs atrial and ventricular contractility. J Gen Physiol. 2016;147(1):39–52.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Cerbai, E., Coppini, R., Sartiani, L., Mugelli, A. (2019). Neural Effects on Cardiac Electrophysiology. In: Govoni, S., Politi, P., Vanoli, E. (eds) Brain and Heart Dynamics. Springer, Cham. https://doi.org/10.1007/978-3-319-90305-7_7-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-90305-7_7-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90305-7
Online ISBN: 978-3-319-90305-7
eBook Packages: Springer Reference MedicineReference Module Medicine